<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02597218</url>
  </required_header>
  <id_info>
    <org_study_id>#2611</org_study_id>
    <nct_id>NCT02597218</nct_id>
  </id_info>
  <brief_title>Incidence of Venous Thromboembolic Disease and Portal Vein Thrombosis After Hepatectomy. A Cohort Study.</brief_title>
  <official_title>Incidence of Venous Thromboembolic Disease and Portal Vein Thrombosis After Hepatectomy in a High-volume Center. A Cohort Study.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hospital Italiano de Buenos Aires</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hospital Italiano de Buenos Aires</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Observational. Retrospective cohort.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Venous thromboembolism (VTE) is a disease that includes both deep vein thrombosis (DVT) and
      pulmonary embolism (PE). It is a common, potentially lethal disorder that can occur among
      postoperative patients. Liver surgery implies a prothrombotic state, as a result of an
      alteration of the equilibrium between synthesis and use of pro and anti coagulant factors
      after a parenquimal resection. The use of antithrombotic prophylaxis following surgery is not
      standarized, and current practices vary depending on the attendant surgeon's particular
      experience or hospital's customs and habits.

      In published research, postoperative patients have been studied as a whole so far. There is
      little evidence regarding patients undergoing hepatectomy. Furthermore, the use and need of
      extended prophylaxis remains unexplored in this group of patients.

      The objetives of the following study are:

        -  To estimate the incidence of symptomatic venous thromboembolism (VTE) [deep vein
           thrombosis (DVT), pulmonary embolism (PE) and fatal PE] in a third level center in
           patients undergoing any hepatectomy within 90 days after surgery.

        -  To estimate the incidence of portal thrombosis (PT) in a third level center in patients
           undergoing any hepatectomy within 90 days after surgery.

        -  To identify and describe factors associated to the development of VTE in patients
           following hepatectomy.

        -  To identify and describe factors associated to the development of PT in patients
           following hepatectomy.

        -  To describe major bleedings or minor but clinically relevant bleedings during the period
           in which those patients received chemical thromboprophylaxis.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>October 2015</start_date>
  <completion_date type="Anticipated">October 2016</completion_date>
  <primary_completion_date type="Anticipated">October 2016</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Venous thromboembolism (VTE)</measure>
    <time_frame>90 days following surgery</time_frame>
    <description>Includes deep vein thrombosis (DVT) and pulmonary embolism (PE)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Portal Thrombosis (PT)</measure>
    <time_frame>90 days following surgery</time_frame>
    <description>Portal thrombosis</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Minor bleeding</measure>
    <time_frame>90 days following surgery</time_frame>
    <description>Any bleeding that doesn't fulfill &quot;major bleeding&quot; criteria.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Major bleeding</measure>
    <time_frame>90 days following surgery</time_frame>
    <description>Any bleeding causing: death, serious threat to life, requirement of active medical intervention, 2 or more red blood cell units transfusion, localized in retroperitoneum, intracraneal or intraocular</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">350</enrollment>
  <condition>Pulmonary Embolism</condition>
  <condition>Venous Thrombosis</condition>
  <condition>Portal Thrombosis</condition>
  <arm_group>
    <arm_group_label>Patients following hepatectomy</arm_group_label>
    <description>Patients following hepatectomy of any type, any gender. Roughly, we will describe: type of resection, presence of cancer,use of mechanical/pharmacological prophylaxis, major/minor bleedings ocurring during observation period.
Outcomes: Venous thromboembolism (VTE)[deep vein thrombosis (DVT) and pulmonary embolism (PE)] and portal thrombosis (PT).</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Patients older than 18 years following hepatectomy of any kind for oncologic/non-oncologic
        disease between 04/09/2012 and 08/28/2015 were enrolled. Follow-up concluded 90 days after
        surgery or at occurence of event (Venous thromboembolism / portal thrombosis / death).
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Older than 18 years old.

          -  Following hepatic surgery.

        Exclusion Criteria:

          -  Living donor

          -  Venous thromboembolism within 6 months previous to surgery.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Martín de Santibañes, Dr</last_name>
    <role>Study Director</role>
    <affiliation>Hospital Italiano de Buenos Aires</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Juan Ignacio Trobbiani, Dr</last_name>
    <phone>+542914253231</phone>
    <email>juan.trobbiani@hospitalitaliano.org.ar</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Juan Cruz Iaquinandi, Dr</last_name>
    <phone>011 69730105</phone>
    <email>juan.iaquinandi@hospitalitaliano.org.ar</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Hospital Italiano de Buenos Aires</name>
      <address>
        <city>Capital Federal</city>
        <state>Buenos Aires</state>
        <zip>1170</zip>
        <country>Argentina</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Juan Ignacio Trobbiani, Dr</last_name>
      <phone>+542914253231</phone>
      <email>juaniitrobbiani@gmail.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Argentina</country>
  </location_countries>
  <reference>
    <citation>Rasmussen MS. Preventing thromboembolic complications in cancer patients after surgery: a role for prolonged thromboprophylaxis. Cancer Treat Rev. 2002 Jun;28(3):141-4. Review.</citation>
    <PMID>12234565</PMID>
  </reference>
  <reference>
    <citation>Ejaz A, Spolverato G, Kim Y, Lucas DL, Lau B, Weiss M, Johnston FM, Kheng M, Hirose K, Wolfgang CL, Haut E, Pawlik TM. Defining incidence and risk factors of venous thromboemolism after hepatectomy. J Gastrointest Surg. 2014 Jun;18(6):1116-24. doi: 10.1007/s11605-013-2432-x. Epub 2013 Dec 13. Erratum in: J Gastrointest Surg. 2014 Apr;18(4):887. Kheng, Marian [corrected to Kheng, Marin].</citation>
    <PMID>24337986</PMID>
  </reference>
  <reference>
    <citation>Caprini JA, Arcelus JI, Hasty JH, Tamhane AC, Fabrega F. Clinical assessment of venous thromboembolic risk in surgical patients. Semin Thromb Hemost. 1991;17 Suppl 3:304-12.</citation>
    <PMID>1754886</PMID>
  </reference>
  <reference>
    <citation>Collins R, Scrimgeour A, Yusuf S, Peto R. Reduction in fatal pulmonary embolism and venous thrombosis by perioperative administration of subcutaneous heparin. Overview of results of randomized trials in general, orthopedic, and urologic surgery. N Engl J Med. 1988 May 5;318(18):1162-73. Review.</citation>
    <PMID>3283548</PMID>
  </reference>
  <reference>
    <citation>Prevention of fatal postoperative pulmonary embolism by low doses of heparin. An international multicentre trial. Lancet. 1975 Jul 12;2(7924):45-51.</citation>
    <PMID>49649</PMID>
  </reference>
  <reference>
    <citation>Kiil J, Kiil J, Axelsen F, Andersen D. Prophylaxis against postoperative pulmonary embolism and deep-vein thrombosis by low-dose heparin. Lancet. 1978 May 27;1(8074):1115-6.</citation>
    <PMID>77413</PMID>
  </reference>
  <reference>
    <citation>Pezzuoli G, Neri Serneri GG, Settembrini P, Coggi G, Olivari N, Buzzetti G, Chierichetti S, Scotti A, Scatigna M, Carnovali M. Prophylaxis of fatal pulmonary embolism in general surgery using low-molecular weight heparin Cy 216: a multicentre, double-blind, randomized, controlled, clinical trial versus placebo (STEP). STEP-Study Group. Int Surg. 1989 Oct-Dec;74(4):205-10.</citation>
    <PMID>2560470</PMID>
  </reference>
  <reference>
    <citation>Mismetti P, Laporte S, Darmon JY, Buchmüller A, Decousus H. Meta-analysis of low molecular weight heparin in the prevention of venous thromboembolism in general surgery. Br J Surg. 2001 Jul;88(7):913-30.</citation>
    <PMID>11442521</PMID>
  </reference>
  <reference>
    <citation>Gould MK, Garcia DA, Wren SM, Karanicolas PJ, Arcelus JI, Heit JA, Samama CM. Prevention of VTE in nonorthopedic surgical patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012 Feb;141(2 Suppl):e227S-e277S. doi: 10.1378/chest.11-2297. Erratum in: Chest. 2012 May;141(5):1369.</citation>
    <PMID>22315263</PMID>
  </reference>
  <reference>
    <citation>Lyman GH, Khorana AA, Kuderer NM, Lee AY, Arcelus JI, Balaban EP, Clarke JM, Flowers CR, Francis CW, Gates LE, Kakkar AK, Key NS, Levine MN, Liebman HA, Tempero MA, Wong SL, Prestrud AA, Falanga A; American Society of Clinical Oncology Clinical Practice. Venous thromboembolism prophylaxis and treatment in patients with cancer: American Society of Clinical Oncology clinical practice guideline update. J Clin Oncol. 2013 Jun 10;31(17):2189-204. doi: 10.1200/JCO.2013.49.1118. Epub 2013 May 13. Review.</citation>
    <PMID>23669224</PMID>
  </reference>
  <reference>
    <citation>Barton JS, Riha GM, Differding JA, Underwood SJ, Curren JL, Sheppard BC, Pommier RF, Orloff SL, Schreiber MA, Billingsley KG. Coagulopathy after a liver resection: is it over diagnosed and over treated? HPB (Oxford). 2013 Nov;15(11):865-71. doi: 10.1111/hpb.12051. Epub 2013 Jan 29.</citation>
    <PMID>23458574</PMID>
  </reference>
  <reference>
    <citation>Bezeaud A, Denninger MH, Dondero F, Saada V, Venisse L, Huisse MG, Belghiti J, Guillin MC. Hypercoagulability after partial liver resection. Thromb Haemost. 2007 Dec;98(6):1252-6.</citation>
    <PMID>18064322</PMID>
  </reference>
  <reference>
    <citation>Tzeng CW, Katz MH, Fleming JB, Pisters PW, Lee JE, Abdalla EK, Curley SA, Vauthey JN, Aloia TA. Risk of venous thromboembolism outweighs post-hepatectomy bleeding complications: analysis of 5651 National Surgical Quality Improvement Program patients. HPB (Oxford). 2012 Aug;14(8):506-13. doi: 10.1111/j.1477-2574.2012.00479.x. Epub 2012 May 15.</citation>
    <PMID>22762398</PMID>
  </reference>
  <reference>
    <citation>Smyrniotis V, Farantos C, Kostopanagiotou G, Arkadopoulos N. Vascular control during hepatectomy: review of methods and results. World J Surg. 2005 Nov;29(11):1384-96. Review.</citation>
    <PMID>16222453</PMID>
  </reference>
  <reference>
    <citation>Yoshiya S, Shirabe K, Nakagawara H, Soejima Y, Yoshizumi T, Ikegami T, Yamashita Y, Harimoto N, Nishie A, Yamanaka T, Maehara Y. Portal vein thrombosis after hepatectomy. World J Surg. 2014 Jun;38(6):1491-7. doi: 10.1007/s00268-013-2440-8.</citation>
    <PMID>24407940</PMID>
  </reference>
  <reference>
    <citation>Weiss MJ, Kim Y, Ejaz A, Spolverato G, Haut ER, Hirose K, Wolfgang CL, Choti MA, Pawlik TM. Venous thromboembolic prophylaxis after a hepatic resection: patterns of care among liver surgeons. HPB (Oxford). 2014 Oct;16(10):892-8. doi: 10.1111/hpb.12278. Epub 2014 May 28.</citation>
    <PMID>24888461</PMID>
  </reference>
  <reference>
    <citation>Tzeng CW, Curley SA, Vauthey JN, Aloia TA. Distinct predictors of pre- versus post-discharge venous thromboembolism after hepatectomy: analysis of 7621 NSQIP patients. HPB (Oxford). 2013 Oct;15(10):773-80. doi: 10.1111/hpb.12130. Epub 2013 Jul 22.</citation>
    <PMID>23869577</PMID>
  </reference>
  <reference>
    <citation>Agnelli G, Bolis G, Capussotti L, Scarpa RM, Tonelli F, Bonizzoni E, Moia M, Parazzini F, Rossi R, Sonaglia F, Valarani B, Bianchini C, Gussoni G. A clinical outcome-based prospective study on venous thromboembolism after cancer surgery: the @RISTOS project. Ann Surg. 2006 Jan;243(1):89-95.</citation>
    <PMID>16371741</PMID>
  </reference>
  <reference>
    <citation>Bergqvist D, Agnelli G, Cohen AT, Eldor A, Nilsson PE, Le Moigne-Amrani A, Dietrich-Neto F; ENOXACAN II Investigators. Duration of prophylaxis against venous thromboembolism with enoxaparin after surgery for cancer. N Engl J Med. 2002 Mar 28;346(13):975-80.</citation>
    <PMID>11919306</PMID>
  </reference>
  <reference>
    <citation>Posadas-Martínez ML, Vázquez FJ, Giunta DH, Waisman GD, de Quirós FG, Gándara E. Performance of the Wells score in patients with suspected pulmonary embolism during hospitalization: a delayed-type cross sectional study in a community hospital. Thromb Res. 2014 Feb;133(2):177-81. doi: 10.1016/j.thromres.2013.11.018. Epub 2013 Nov 25.</citation>
    <PMID>24342535</PMID>
  </reference>
  <verification_date>November 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 3, 2015</study_first_submitted>
  <study_first_submitted_qc>November 3, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 5, 2015</study_first_posted>
  <last_update_submitted>November 4, 2015</last_update_submitted>
  <last_update_submitted_qc>November 4, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 6, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Hospital Italiano de Buenos Aires</investigator_affiliation>
    <investigator_full_name>Diego Hernan Giunta, MD</investigator_full_name>
    <investigator_title>MD</investigator_title>
  </responsible_party>
  <keyword>Hepatectomy</keyword>
  <keyword>Prophylaxis</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Thrombosis</mesh_term>
    <mesh_term>Embolism</mesh_term>
    <mesh_term>Pulmonary Embolism</mesh_term>
    <mesh_term>Venous Thrombosis</mesh_term>
    <mesh_term>Thromboembolism</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

